Atlas Trials

Autologous Stem Cell Transplant Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoma

Clinical trial NCT00005803 · COMPLETED

Trial details

NCT number
NCT00005803
Sponsor
Fred Hutchinson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Prolymphocytic LeukemiaRecurrent Adult Hodgkin LymphomaRecurrent Childhood Hodgkin LymphomaRecurrent Childhood Non-Hodgkin LymphomaRecurrent Chronic Lymphocytic LeukemiaRecurrent Non-Hodgkin LymphomaRecurrent Small Lymphocytic LymphomaRefractory Childhood Hodgkin LymphomaRefractory Chronic Lymphocytic LeukemiaRefractory Hodgkin LymphomaRefractory Non-Hodgkin LymphomaRefractory Small Lymphocytic Lymphoma
Start date
1999-09-01
Primary completion
2016-01-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.